A deployable Explainable AI (XAI) framework for dysglycemia screening in Indonesia that was deployed as an Android application combining visual SHAP explanations with LLM-generated narratives illustrates an approach for developing transparent, population-representative mHealth AI that is meaningful and accessible to its intended users.
Abstract
Deploying trustworthy AI requires more than predictive accuracy; it demands population-representative data, transparent explainability, and user-centered design. Despite rapid mobile penetration across Southeast Asia, existing AI-based health tools remain predominantly trained on non-representative datasets and function as opaque black-box systems, limiting clinical trust. This study addresses these gaps through a deployable Explainable AI (XAI) framework for dysglycemia screening in Indonesia. Features were extracted from the Indonesia Family Life Survey 5 (IFLS5), a nationally representative longitudinal survey (\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\sim $$\end{document}83% of the Indonesian population), using its measured HbA1c-based labels for dysglycemia screening. Feature selection employed a four-stage XAI-in-the-loop pipeline combining literature review, statistical filtering, domain expert consultation, and SHAP-based evaluation. Among models trained, XGBoost achieved the highest performance (ROC-AUC = 0.72), with SHAP used both for post-hoc interpretation and feature selection. SHAP analysis indicated clinical alignment, with age, BMI, and hypertension as dominant risk factors, including a non-linear risk increase after age 45. The model was deployed as an Android application combining visual SHAP explanations with LLM-generated narratives. A pilot evaluation (n = 12) returned a mean comprehension score of 4.31/5. The framework illustrates an approach for developing transparent, population-representative mHealth AI that is meaningful and accessible to its intended users.
Abstract Mendelian randomization (MR) has been widely used to infer causal relationships between exposures and outcomes in epidemiological studies. However, classical MR assumptions can be violated when genetic variants are associated with outcomes through pathways other than the exposure, leading to uncorrelated and/o...
The ACute COPD Exacerbation Prediction Tool (ACCEPT) is an algorithm for predicting 12-month risk of chronic obstructive pulmonary disease (COPD) exacerbations suitable for international use and recalibrated ACCEPT 2.0 to incorporate country-specific background exacerbation risk, using multi-country data from NOVELTY.
L. Lim, J. Mehareen, Amin Adibi et al.· Diagnostic and Prognostic Re...· 0 citations
Frequentist and Bayesian meta-analyses are performed to compare uncertainty quantification and applicability for risk assessment using lead exposure and children’s IQ as a case study.
P. Sell, Margaux Sanchez, P. Palmont et al.· BMC Medical Research Methodo...· 0 citations
MIT professors Adam Berinsky and Chara Podimata discuss a new project to track how AI chatbots are responding to questions about the 2026 U.S. midterm elections.
Microsoft Research Blog· microsoft.comOct 30, 2026
Evaluating Microsoft Copilot at enterprise scale requires test data that captures the full complexity of real organizations, yet real enterprise data contains sensitive information that cannot be used for evaluation under any circumstances. The post From synthetic enterprise data evaluations to real Microsoft Copilot AI confidence appeared first on Microsoft Research.
Critical flaws, compromised release channels and agentic AI threats landed within days of each other in mid-October 2026. Why “Black October” may say more about how well we now find weaknesses than about the attacks themselves. The post Black October? The Week AI Changed the Cybersecurity Conversation appeared first on GPT-Lab.
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.